M

MedPharmics, LLC | Gulfport, MS

Research site

(Unclaimed)

Location

15190 Community Road, Gulfport, Mississippi, United States of America

Site insights

Top conditions

Top treatments

Orforglipron

Galcanezumab

NVX-Cov2373

LY3502970

Parent organization

This site is a part of MedPharmics, LLC

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 18 total trials

A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040) (ADVANCE)

The purpose of this pediatric, chronic weight management, Phase 3 Master Protocol (PWMP) is to create a framework to evaluate the safety and efficacy...

Not yet enrolling

Overweight

Obesity

Drug: Orforglipron

Drug: Placebo

A Study of Orforglipron (LY3502970) in Adolescent Participants With Obesity, or Overweight With Related Comorbidities

The main purpose of this study, performed under Master Protocol J4M-MC-PWMP, is to evaluate the efficacy, safety, and pharmacokinetics of orforglipro...

Not yet enrolling

Overweight

Obesity

Drug: Orforglipron

Drug: Placebo

A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Healthy Participants 16 to 40 Years of Age

The main purpose of this study is to evaluate the efficacy of mRNA 1647 vaccine in CMV-seronegative female participants and to evaluate the safety an...

Active, not recruiting

Cytomegalovirus Infection

Biological: mRNA-1647

Biological: Placebo